Cytokinetics Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Cytokinetics Inc. filed 86 open-market sales worth $51.8 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Malik Fady Ibraham, EVP Research & Development, sold 3,500 shares at $61.38 on 6 October 2026, filed 6 October 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 6 October 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $61.38 | $214,830 | Form 4 |
| 28 September 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $65.46 | $490,950 | Form 4 |
| 22 September 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $68.29 | $239,015 | Form 4 |
| 15 September 2026 | Landry Robert E | Director | Sale | 1,000 | $72.13 | $72,130 | Form 4 |
| 15 September 2026 | Blum Robert I | President & CEO | Sale | 97,926 | $69.33 | $6.8 million | Form 4 |
| 14 September 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $73.44 | $550,800 | Form 4 |
| 11 September 2026 | Landry Robert E | Director | Sale | 1,000 | $74.66 | $74,660 | Form 4 |
| 8 September 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $75.46 | $264,110 | Form 4 |
| 1 September 2026 | Parshall B Lynne | Director | Sale | 5,000 | $71.48 | $357,400 | Form 4 |
| 31 August 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 10,000 | $70.24 | $702,400 | Form 4 |
| 31 August 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $70.24 | $526,800 | Form 4 |
| 18 August 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $75.82 | $265,370 | Form 4 |
| 10 August 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $76.76 | $575,700 | Form 4 |
| 30 July 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 14,000 | $79.88 | $1.1 million | Form 4 |
| 27 July 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $80.87 | $606,525 | Form 4 |
| 21 July 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $80.59 | $282,065 | Form 4 |
| 13 July 2026 | Blum Robert I | President & CEO | Sale | 10 | $82.02 | $820 | Form 4 |
| 13 July 2026 | Blum Robert I | President & CEO | Sale | 7,490 | $82.02 | $614,330 | Form 4 |
| 7 July 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $86.62 | $303,170 | Form 4 |
| 1 July 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $84.92 | $636,900 | Form 4 |
| 1 July 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 15,000 | $85.80 | $1.3 million | Form 4 |
| 1 July 2026 | Lee Sung | EVP, Chief Financial Officer | Sale | 1,112 | $87.79 | $97,622 | Form 4 |
| 29 June 2026 | Lee Sung | EVP, Chief Financial Officer | Sale | 3,134 | $85.00 | $266,390 | Form 4 |
| 24 June 2026 | Lee Sung | EVP, Chief Financial Officer | Sale | 38,730 | $82.30 | $3.2 million | Form 4 |
| 23 June 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $79.51 | $278,285 | Form 4 |
| 15 June 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $70.46 | $528,450 | Form 4 |
| 9 June 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $67.98 | $237,930 | Form 4 |
| 1 June 2026 | Kaye Edward M. Md | Director | Sale | 2,933 | $76.09 | $223,172 | Form 4 |
| 1 June 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 15,000 | $74.08 | $1.1 million | Form 4 |
| 1 June 2026 | Parshall B Lynne | Director | Sale | 5,000 | $74.08 | $370,400 | Form 4 |
| 27 May 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $77.21 | $579,075 | Form 4 |
| 19 May 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $75.69 | $264,915 | Form 4 |
| 14 May 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $77.92 | $584,400 | Form 4 |
| 5 May 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $77.37 | $270,795 | Form 4 |
| 5 May 2026 | Wierenga Wendell | Director | Sale | 4,032 | $75.00 | $302,400 | Form 4 |
| 5 May 2026 | Lee Sung | EVP, Chief Financial Officer | Sale | 23,906 | $76.87 | $1.8 million | Form 4 |
| 5 May 2026 | Henderson John T | Director | Sale | 20,000 | $75.97 | $1.5 million | Form 4 |
| 5 May 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 11,333 | $77.25 | $875,474 | Form 4 |
| 1 May 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 15,857 | $65.00 | $1.0 million | Form 4 |
| 30 April 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 15,000 | $63.26 | $948,900 | Form 4 |
| 29 April 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $59.62 | $447,150 | Form 4 |
| 21 April 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $65.69 | $229,915 | Form 4 |
| 15 April 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 7,449 | $66.02 | $491,783 | Form 4 |
| 15 April 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $65.38 | $490,350 | Form 4 |
| 7 April 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 3,500 | $65.21 | $228,235 | Form 4 |
| 7 April 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 1,000 | $64.75 | $64,750 | Form 4 |
| 1 April 2026 | Blum Robert I | President & CEO | Sale | 7,500 | $66.63 | $499,725 | Form 4 |
| 31 March 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 3,639 | $65.00 | $236,535 | Form 4 |
| 18 March 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 1,930 | $62.07 | $119,795 | Form 4 |
| 17 March 2026 | Lee Sung | EVP, Chief Financial Officer | Sale | 4,935 | $62.15 | $306,710 | Form 4 |
| 17 March 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 5,626 | $62.15 | $349,656 | Form 4 |
| 17 March 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 2,916 | $62.15 | $181,229 | Form 4 |
| 17 March 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 7,636 | $62.15 | $474,577 | Form 4 |
| 17 March 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 4,397 | $62.15 | $273,274 | Form 4 |
| 17 March 2026 | Blum Robert I | President & CEO | Sale | 12,673 | $62.15 | $787,627 | Form 4 |
| 17 March 2026 | Blum Robert I | President & CEO | Sale | 23,928 | $62.15 | $1.5 million | Form 4 |
| 16 March 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 1,709 | $61.03 | $104,300 | Form 4 |
| 9 March 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 2,582 | $60.72 | $156,779 | Form 4 |
| 9 March 2026 | Malik Fady Ibraham | EVP Research & Development | Sale | 2,907 | $60.72 | $176,513 | Form 4 |
| 9 March 2026 | Blum Robert I | President & CEO | Sale | 7,931 | $60.72 | $481,570 | Form 4 |
| 5 March 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 15,000 | $61.87 | $928,050 | Form 4 |
| 5 March 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 11,000 | $61.88 | $680,680 | Form 4 |
| 2 March 2026 | Parshall B Lynne | Director | Sale | 5,000 | $61.21 | $306,050 | Form 4 |
| 2 March 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 886 | $61.62 | $54,595 | Form 4 |
| 5 February 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 15,000 | $61.93 | $928,950 | Form 4 |
| 2 February 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 886 | $62.10 | $55,021 | Form 4 |
| 5 January 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 15,000 | $60.28 | $904,200 | Form 4 |
| 2 January 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 913 | $62.09 | $56,688 | Form 4 |
| 2 January 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 885 | $63.16 | $55,897 | Form 4 |
| 29 December 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 1,809 | $62.44 | $112,954 | Form 4 |
| 22 December 2025 | Wierenga Wendell | Director | Sale | 20,000 | $66.14 | $1.3 million | Form 4 |
| 16 December 2025 | Malik Fady Ibraham | EVP Research & Development | Sale | 2,200 | $61.24 | $134,728 | Form 4 |
| 8 December 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 1,042 | $65.96 | $68,730 | Form 4 |
| 5 December 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sale | 52,486 | $65.95 | $3.5 million | Form 4 |
| 2 December 2025 | Henderson John T | Director | Sale | 8,750 | $63.90 | $559,125 | Form 4 |
| 2 December 2025 | Malik Fady Ibraham | EVP Research & Development | Sale | 2,200 | $63.89 | $140,558 | Form 4 |
| 1 December 2025 | Kaye Edward M. Md | Director | Sale | 28,064 | $66.72 | $1.9 million | Form 4 |
| 1 December 2025 | Harrington Robert Arthur | Director | Sale | 2,150 | $66.80 | $143,620 | Form 4 |
| 19 November 2025 | Parshall B Lynne | Director | Sale | 5,000 | $64.73 | $323,650 | Form 4 |
| 18 November 2025 | Malik Fady Ibraham | EVP Research & Development | Sale | 2,200 | $66.45 | $146,190 | Form 4 |
| 11 November 2025 | Kaye Edward M. Md | Director | Sale | 5,175 | $65.08 | $336,789 | Form 4 |
| 4 November 2025 | Malik Fady Ibraham | EVP Research & Development | Sale | 2,295 | $59.55 | $136,667 | Form 4 |
| 30 October 2025 | Blum Robert I | President & CEO | Sale | 5,000 | $62.86 | $314,300 | Form 4 |
| 27 October 2025 | Wierenga Wendell | Director | Sale | 4,375 | $58.68 | $256,725 | Form 4 |
| 21 October 2025 | Malik Fady Ibraham | EVP Research & Development | Sale | 2,105 | $58.22 | $122,553 | Form 4 |
| 16 October 2025 | Blum Robert I | President & CEO | Sale | 5,000 | $60.03 | $300,150 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Cytokinetics Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.